+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Telecare Market Size, Share & Industry Trends Analysis Report By Product Type, By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 83 Pages
  • March 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5590201
The Latin America, Middle East and Africa Telecare Market is expected to witness market growth of 9.9% CAGR during the forecast period (2021 2027).

Telecare applications have proven to be effective in providing patients with appropriate care and lowering the likelihood of unpleasant events and symptoms going unreported. The internet of things along with advanced healthcare analytics, as well as smart wearable gadgets and robust internet and smartphone connectivity, are transforming the telehealth business and allowing for flawless patient monitoring and effective chronic illness management. Additionally, by combining AI with machine learning algorithms, healthcare services can now be more personalized.

In the midst of a crisis, the healthcare industry changed its delivery systems. However, both clinicians and patients have learned to appreciate the advantages of telehealth. It can also be called by various names such as telemedicine, tele-education, e-health, remote medicine, mobile health, telemedical, mobile health, and m-Health, which has evolved into a strong and widely accepted new technology in its numerous forms and purposes. By incorporating tech-enabled delivery into the healthcare mix, more patients can be reached, the patient experience can be improved, and the consistency of treatment can be increased.

According to the International Trade Administration, Nigeria's healthcare infrastructure is still underdeveloped and only comprises a few modern medical facilities. The healthcare metrics in the country are among the lowest in Africa. It has one of the world's fastest-growing populations, with 5.5 live births per woman and a 3.2 percent annual population growth rate, and is expected to surpass 400 million people by 2050. Also, according to WHO estimates, medical professionals are in low supply, with only approximately 35,000 doctors available against a demand of 237,000, partially due to the significant migration of healthcare workers to other places. Moreover, according to the Nigerian Medical Association, medical tourism costs Nigeria at least $1.5 billion every year (NMA). This factor is expected to facilitate the penetration of telecare services across the region.

The Brazil market dominated the LAMEA Telecare Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $102.7 million by 2027. The Argentina market is anticipated to grow at a CAGR of 10.5% during (2021 - 2027). Additionally, The UAE market is expected to exhibit a CAGR of 9.6% during (2021 - 2027).

Based on Product Type, the market is segmented into Activity Monitoring and Remote Medication Management. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, AllScripts Healthcare Solutions, Inc., AT&T, Inc., Samsung Electronics Co., Ltd., Apple, Inc., Qualcomm, Inc., and Google LLC.

Scope of the Study


Market Segments Covered in the Report:


By Product Type

  • Activity Monitoring
  • Remote Medication Management

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Pfizer, Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • AllScripts Healthcare Solutions, Inc.
  • AT&T, Inc.
  • Samsung Electronics Co., Ltd.
  • Apple, Inc.
  • Qualcomm, Inc.
  • Google LLC

Unique Offerings from the publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Telecare Market, by Product Type
1.4.2 LAMEA Telecare Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Publisher Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2020, Mar - 2021, Dec) Leading Players
Chapter 4. LAMEA Telecare Market by Product Type
4.1 LAMEA Activity Monitoring Market by Country
4.2 LAMEA Remote Medication Management Market by Country
Chapter 5. LAMEA Telecare Market by Country
5.1 Brazil Telecare Market
5.1.1 Brazil Telecare Market by Product Type
5.2 Argentina Telecare Market
5.2.1 Argentina Telecare Market by Product Type
5.3 UAE Telecare Market
5.3.1 UAE Telecare Market by Product Type
5.4 Saudi Arabia Telecare Market
5.4.1 Saudi Arabia Telecare Market by Product Type
5.5 South Africa Telecare Market
5.5.1 South Africa Telecare Market by Product Type
5.6 Nigeria Telecare Market
5.6.1 Nigeria Telecare Market by Product Type
5.7 Rest of LAMEA Telecare Market
5.7.1 Rest of LAMEA Telecare Market by Product Type
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Pfizer, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.3 Sanofi S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Johnson and Johnson
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental &Regional Analysis
6.4.4 Research & Development Expenses
6.5 AllScripts Healthcare Solutions, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 AT&T, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Samsung Electronics Co., Ltd. (Samsung Group)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Product Launches and Product Expansions:
6.7.6 SWOT Analysis
6.8 Apple, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Product and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.6 SWOT Analysis
6.9 Qualcomm, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.9.5 SWOT Analysis
6.10. Google LLC
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expense
6.10.5 Recent strategies and developments:
6.10.5.1 Partnerships, Collaborations, and Agreements:
6.10.6 SWOT Analysis

Companies Mentioned

  • Abbott Laboratories
  • Pfizer, Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • AllScripts Healthcare Solutions, Inc.
  • AT&T, Inc.
  • Samsung Electronics Co., Ltd.
  • Apple, Inc.
  • Qualcomm, Inc.
  • Google LLC

Methodology

Loading
LOADING...